For leaders preparing for 2026, a critical step is to map where processes should remain human or become automated. Audit your ...

Comprehensive Analysis of Tirzepatide Access Options as Resolution Season Peaks: MyStart Health Programs, FDA Context, Coverage Developments, and Questions to Consider Before Starting GLP-1 ...

Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...

At King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh, managing emergency department congestion has become a system-wide operational priority rather than a localized clinical ...

At King Faisal Specialist Hospital & Research Centre (KFSHRC), patient safety is closely linked to the hospital’s ability to reach accurate diagnoses when standard clinical tools fall short. This is ...

The integration of AI has the potential to enhance oncology clinical pathways, but there are important judgment calls that must be made before this technology can be fully implemented. The quest to ...

The progress in understanding the pathophysiology of hidradenitis suppurativa appears to be leading to treatment strategies ...

A new proposal in JAMA Internal Medicine suggests that the FDA should create an approval pathway for medical AI tools that parallels how physicians are trained and licensed.

Background In 2024, the UK National Institute of Health and Care Excellence (NICE) recommended TriageHF alerts as an option ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

OneOncology supports 33 practices, providing infrastructure and expertise for advanced therapies and value-based care, while ...

In every exam room, behind every treatment decision and embedded in every line of a care pathway lies an invisible tension: ...